Bordas-Le Floch Véronique, Le Mignon Maxime, Bouley Julien, Groeme Rachel, Jain Karine, Baron-Bodo Véronique, Nony Emmanuel, Mascarell Laurent, Moingeon Philippe
Stallergenes, 6 rue Alexis de Tocqueville, 92183, Antony cedex, France.
PLoS One. 2015 Aug 28;10(8):e0136258. doi: 10.1371/journal.pone.0136258. eCollection 2015.
Allergy to short ragweed (Ambrosia artemisiifolia) pollen is a serious and expanding health problem in North America and Europe. Whereas only 10 short ragweed pollen allergens are officially recorded, patterns of IgE reactivity observed in ragweed allergic patients suggest that other allergens contribute to allergenicity. The objective of the present study was to identify novel allergens following extensive characterization of the transcriptome and proteome of short ragweed pollen.
Following a Proteomics-Informed-by-Transcriptomics approach, a comprehensive transcriptomic data set was built up from RNA-seq analysis of short ragweed pollen. Mass spectrometry-based proteomic analyses and IgE reactivity profiling after high resolution 2D-gel electrophoresis were then combined to identify novel allergens.
Short ragweed pollen transcripts were assembled after deep RNA sequencing and used to inform proteomic analyses, thus leading to the identification of 573 proteins in the short ragweed pollen. Patterns of IgE reactivity of individual sera from 22 allergic patients were assessed using an aqueous short ragweed pollen extract resolved over 2D-gels. Combined with information derived from the annotated pollen proteome, those analyses revealed the presence of multiple unreported IgE reactive proteins, including new Amb a 1 and Amb a 3 isoallergens as well as 7 novel candidate allergens reacting with IgEs from 20-70% of patients. The latter encompass members of the carbonic anhydrase, enolase, galactose oxidase, GDP dissociation inhibitor, pathogenesis related-17, polygalacturonase and UDP-glucose pyrophosphorylase families.
We extended the list of allergens identified in short ragweed pollen. These findings have implications for both diagnosis and allergen immunotherapy purposes.
对短豚草(Ambrosia artemisiifolia)花粉过敏是北美和欧洲一个严重且日益普遍的健康问题。虽然官方仅记录了10种短豚草花粉过敏原,但在豚草过敏患者中观察到的IgE反应模式表明,其他过敏原也会导致过敏。本研究的目的是在对短豚草花粉转录组和蛋白质组进行广泛表征后,鉴定新的过敏原。
采用转录组学指导的蛋白质组学方法,通过对短豚草花粉的RNA测序分析建立了一个全面的转录组数据集。然后将基于质谱的蛋白质组分析与高分辨率二维凝胶电泳后的IgE反应谱相结合,以鉴定新的过敏原。
通过深度RNA测序组装了短豚草花粉转录本,并用于指导蛋白质组分析,从而鉴定出短豚草花粉中的573种蛋白质。使用在二维凝胶上分离的短豚草花粉水提取物评估了22名过敏患者个体血清的IgE反应模式。结合注释花粉蛋白质组的信息,这些分析揭示了多种未报告的IgE反应性蛋白质的存在,包括新的Amb a 1和Amb a 3同种过敏原,以及7种新的候选过敏原,它们与20%-70%患者的IgE发生反应。后者包括碳酸酐酶、烯醇酶、半乳糖氧化酶、GDP解离抑制剂、病程相关蛋白17、多聚半乳糖醛酸酶和UDP-葡萄糖焦磷酸化酶家族的成员。
我们扩展了短豚草花粉中已鉴定过敏原的列表。这些发现对诊断和过敏原免疫治疗都有意义。